Cancer drug candidate developed using supercomputing & AI blocks tumor growth without toxic side effect
June 26, 2025
June 26, 2025
LIVERMORE, California, June 26 -- The U.S. Department of Energy Lawrence Livermore National Laboratory issued the following news:
* * *
Cancer drug candidate developed using supercomputing & AI blocks tumor growth without toxic side effect
*
A new cancer drug candidate developed by Lawrence Livermore National Laboratory (LLNL), (link is external) BBOT (BridgeBio Oncology Therapeutics) and the (link is external) Frederick National Laboratory . . .
* * *
Cancer drug candidate developed using supercomputing & AI blocks tumor growth without toxic side effect
*
A new cancer drug candidate developed by Lawrence Livermore National Laboratory (LLNL), (link is external) BBOT (BridgeBio Oncology Therapeutics) and the (link is external) Frederick National Laboratory . . .